ABUS vs CDW
Arbutus Biopharma Corp (ABUS) versus CDW Corp (CDW) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
CDW Corp (CDW) is a information technology services company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported CDW revenue for 2024-12-31 was $21.00B. Net income was $1.08B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
Not investment advice. Open the ABUS and CDW stock pages for the full models.
Not investment advice.